Jefferies Financial Group Inc. Trims Stock Holdings in The Clorox Company $CLX

Jefferies Financial Group Inc. reduced its stake in The Clorox Company (NYSE:CLX) by 45.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 9,615 shares of the company’s stock after selling 7,981 shares during the period. Jefferies Financial Group Inc.’s holdings in Clorox were worth $969,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Legato Capital Management LLC purchased a new stake in Clorox in the 4th quarter valued at about $393,000. Axxcess Wealth Management LLC raised its holdings in Clorox by 53.9% in the 4th quarter. Axxcess Wealth Management LLC now owns 16,274 shares of the company’s stock valued at $1,641,000 after buying an additional 5,698 shares during the period. Diamant Asset Management Inc. raised its holdings in Clorox by 6.8% in the 4th quarter. Diamant Asset Management Inc. now owns 2,403 shares of the company’s stock valued at $242,000 after buying an additional 153 shares during the period. Meiji Yasuda Asset Management Co Ltd. raised its holdings in Clorox by 4.0% in the 4th quarter. Meiji Yasuda Asset Management Co Ltd. now owns 49,705 shares of the company’s stock valued at $5,012,000 after buying an additional 1,894 shares during the period. Finally, Global Retirement Partners LLC raised its holdings in Clorox by 119.9% in the 4th quarter. Global Retirement Partners LLC now owns 3,894 shares of the company’s stock valued at $393,000 after buying an additional 2,123 shares during the period. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Stock Down 0.9%

Shares of NYSE:CLX opened at $96.19 on Friday. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The firm has a market capitalization of $11.63 billion, a PE ratio of 15.62, a price-to-earnings-growth ratio of 0.50 and a beta of 0.59. The firm’s 50-day moving average is $98.82 and its two-hundred day moving average is $105.92. The Clorox Company has a 1 year low of $84.70 and a 1 year high of $132.03.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period in the prior year, the firm earned $1.45 earnings per share. The business’s revenue for the quarter was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Analysts predict that The Clorox Company will post 5.61 EPS for the current year.

Insider Transactions at Clorox

In other Clorox news, Director Pierre R. Breber purchased 5,000 shares of the stock in a transaction that occurred on Tuesday, May 5th. The stock was purchased at an average cost of $85.82 per share, with a total value of $429,100.00. Following the completion of the acquisition, the director directly owned 18,000 shares of the company’s stock, valued at $1,544,760. This trade represents a 38.46% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.63% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

CLX has been the topic of several research analyst reports. Weiss Ratings upgraded shares of Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, April 13th. Morgan Stanley reduced their price objective on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a report on Friday, May 1st. Citigroup reduced their price objective on shares of Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a report on Friday, May 1st. Wells Fargo & Company cut their price target on shares of Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a research note on Monday, May 18th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $91.00 price target on shares of Clorox in a research note on Friday, May 1st. One research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Reduce” and a consensus target price of $103.40.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.